1. India Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Godavari Drugs Limited

Godavari Drugs Limited

GODAVARI.BO
Godavari Drugs LimitedIN flagBombay Stock Exchange
125.40
INR
+1.40
- -
944.33MMarket Cap

Total Valuation

Godavari Drugs Limited carries a market capitalization of 944.33M, placing it among publicly traded companies globally. Its enterprise value stands at 1.27B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap944.33M
Enterprise Value1.27B

Share Statistics

Godavari Drugs Limited currently has 10.13M shares outstanding.

Shares Outstanding10.13M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Godavari Drugs Limited trades at a trailing price-to-earnings ratio of 15.84. The price-to-sales ratio is 0.61, and the price-to-book ratio stands at 6.39.

PE Ratio15.84
PS Ratio0.61
PB Ratio6.39
P/TBV Ratio0.85
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Godavari Drugs Limited trades at an EV/EBITDA multiple of 16.06 and an EV/FCF ratio of 39.39. The EV/Sales ratio of 1.20 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 16.06 provides insight into valuation relative to core operating earnings.

EV / Sales1.20
EV / EBITDA16.06
EV / EBIT16.06
EV / FCF39.39

Financial Position

Godavari Drugs Limited maintains a current ratio of 1.31, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 100.74, indicating elevated leverage, while an interest coverage ratio of 1.98 demonstrates limited ability to service its debt obligations.

Current Ratio1.31
Quick Ratio0.17
Debt / Equity100.74
Debt / EBITDA9.69
Interest Coverage1.98

Financial Efficiency

Godavari Drugs Limited posts a return on equity of 19.42 and a return on invested capital of 4.86.

Return on Equity (ROE)19.42
Return on Assets (ROA)2.38
Return on Invested Capital (ROIC)4.86
Return on Capital Employed (ROCE)7.99
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.09

Taxes

Over the trailing twelve months, Godavari Drugs Limited has paid 9.73M in income taxes, reflecting an effective tax rate of 19.22.

Income Tax9.73M
Effective Tax Rate19.22

Stock Price Statistics

Godavari Drugs Limited's stock has gained approximately 39.33333% over the past 52 weeks. The 50-day moving average sits at 124.04, while the 200-day moving average is 95.05.

Beta (5Y)N/A
52-Week Price Change39.33333%
50-Day Moving Average124.04
200-Day Moving Average95.05
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Godavari Drugs Limited generated 1.06B in revenue and converted that into 40.90M in net income, yielding earnings per share of 5.37. EBITDA reached 78.83M, while operating income came in at 78.83M.

Revenue1.06B
Gross Profit283.11M
Operating Income78.83M
Pretax Income50.63M
Net Income40.90M
EBITDA78.83M
EBIT78.83M
Earnings Per Share (EPS)5.37

Balance Sheet

Godavari Drugs Limited holds 145.09M in cash and equivalents against 763.58M in total debt, resulting in a net debt position of 618.49M. Total book value stands at 101.27M, with working capital of 266.52M providing operational flexibility.

Cash & Cash Equivalents145.09M
Total Debt763.58M
Net Debt618.49M
Equity (Book Value)101.27M
Book Value Per Share13.45
Working Capital266.52M

Margins

Godavari Drugs Limited operates with a gross margin of 26.76, reflecting its pricing power and cost economics. The operating margin of 7.45 and net profit margin of 3.87 provide insight into operational efficiency.

Gross Margin26.76
Operating Margin7.45
Pretax Margin4.79
Profit Margin3.87
EBITDA Margin7.45

Scores

Godavari Drugs Limited posts an Altman Z-Score of 1.13, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.13